The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic ...

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

Lung cancer remains one of the leading causes of cancer deaths around the world. Among the different types of lung cancer, ...

Background We describe the occurrence of second primary lung cancers (SPLCs) and their determinant in Sweden. Methods Nation-wide cancer registry from years 1961 to 2021 identified a total of 853 ...

The largest ever study of non-meat diets and cancer risk has found that vegetarian diets are associated with lower risks of several cancers—breast, prostate, kidney and pancreatic cancers, and ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...

Abstract: Early detection of lung cancer is paramount for improved patient outcomes and reduced mortality rates. This research presented an innovative methodology combining machine learning with ...

Lung cancer is the second most common malignancy in the United States. Lung cancers are broadly divided into small cell and non-small cell lung cancer (SCLC and NSCLC, respectively). SCLC is a ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer ...

Squamous cell carcinoma of the lung is linked to smoking and requires early detection and accurate staging for effective treatment. Diagnosis involves imaging and biopsy, with the TNM system used to ...

In what could be a “game changer” someday for Kentuckians with small cell lung cancer, the University of Kentucky Markey Cancer Center has treated the first patient in the country with a novel drug ...